Skip to main content
CNXU logo

Conexeu Sciences Inc.

CNXUNASDAQHealthcareBiotechnology

$3.95Today:- (-)

As of Oct 15, 2026 close

Market cap
$106.54M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$3.05$18.79
Volume (live)
-
Avg. volume (3M)
267.91K

Conexeu Sciences (CNXU) Income Statement

In fiscal 2025 (fiscal year ended Oct 31, 2025), Conexeu Sciences posted a net loss of $3.92M, compared with a net loss of $471.87K a year earlier.

Conexeu Sciences Income Statement Analysis

Values in millions USD

Income StatementBalance SheetCash FlowRatios
Scroll to see more
Conexeu Sciences Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023
Period endingOct 2025Oct 2024Oct 2023
Revenue & Gross Profit
Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research & Development0.270.24-
Selling, General & Administrative3.660.410.04
Operating Expenses3.960.640.04
Operating Income-3.96-0.64-0.04
Other Income/Expense
Interest Income0.00--
Interest Expense0.000.02-
Other Income/Expense0.040.170.00
Income
Income Before Tax-3.92-0.47-0.04
Income Tax Expense---
Net Income-3.92-0.47-0.04
Net Income - Continuous Operations-3.92-0.47-
Net Income - Discontinued Operations---
EBITDA-3.93-0.64-0.04
EBIT-3.95-0.64-0.04
Depreciation & Amortization0.02--
Earnings Per Share
Basic EPS---
Diluted EPS---
Basic Shares Outstanding12.646.731.74
Diluted Shares Outstanding12.646.731.74

Source: Company financial statements from annual and quarterly filings. Data as of Jul 31, 2026. Data sources and methodology

Frequently Asked Questions About Conexeu Sciences Financial Statements

Is Conexeu Sciences profitable?

No. Conexeu Sciences reported a net loss of $3.92M in fiscal 2025. In fiscal 2024 it lost $471.87K.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition